Usefulness of Left Ventricular Vortex Flow Analysis for Predicting Clinical Outcomes in Patients with Chronic Heart

In-Cheol Kim1, Geu-Ru Hong2, Gianni Pedrizzetti3

  • 1Division of Cardiology, Cardiovascular Center, Yonsei University College of Medicine, Seoul, Korea; Division of Cardiology, Keimyung University, Dongsan Medical Center, Daegu, Korea.

Insights

Left ventricular vortex flow parameters, specifically kinetic energy fluctuation (KEF) measured by contrast echocardiography, can improve the prediction of major adverse cardiac events (MACE) in heart failure patients. Higher KEF indicates a lower risk of MACE.

Area of Science:

  • Cardiology
  • Medical Imaging
  • Fluid Dynamics

Background:

  • Chronic heart failure with systolic dysfunction poses a significant risk for major adverse cardiac events (MACE).
  • Accurate prediction of MACE is crucial for effective patient management and treatment strategies.
  • Current predictive models may not fully capture the complex pathophysiology of heart failure.

Purpose of the Study:

  • To evaluate if left ventricular vortex flow parameters, assessed via contrast echocardiography, enhance MACE prediction in patients with chronic heart failure and systolic dysfunction.
  • To investigate the association between kinetic energy fluctuation (KEF) and the risk of MACE.
  • To determine if KEF improves the predictive capability of existing clinical models.

Main Methods:

  • Prospective enrollment of 75 patients with systolic dysfunction (ejection fraction ≤45%) undergoing contrast echocardiography.
  • Vortex flow analysis using particle image velocimetry to quantify parameters like KEF.
  • Follow-up for MACE, defined as cardiovascular hospital admission or cardiac death.

Main Results:

  • 29 patients (38.7%) experienced MACE during a median follow-up of 277 days.
  • Patients with MACE had higher diabetes incidence and E/e' ratio, and lower hemoglobin and ejection fraction.
  • Significantly lower KEF was observed in patients with MACE.
  • Higher KEF was independently associated with a lower risk of MACE (HR=0.18, p=0.046).

Conclusions:

  • Quantitative left ventricular vortex flow parameter KEF, assessed by contrast echocardiography, is a valuable predictor of MACE in heart failure patients.
  • KEF improves the discrimination of MACE risk when added to conventional clinical parameters.
  • Elevated KEF is linked to a reduced risk of MACE and better functional status in this patient cohort.

Related Concept Videos

Heart Failure III: Clinical Manifestations01:26

Heart Failure III: Clinical Manifestations

Heart failure (HF) manifests primarily as dyspnea, fatigue, and fluid retention, resulting in peripheral and pulmonary edema. Symptoms may vary depending on which ventricle is more affected, left or right.Left-Sided Heart FailureAlso known as left ventricular failure, this condition results from the left ventricle's inability to fill or eject sufficient blood into the systemic circulation. It leads to pulmonary congestion, which occurs when the left ventricle fails to eject blood effectively...
612
Predicting Reaction Outcomes02:24

Predicting Reaction Outcomes

Kinetics describes the rate and path by which a reaction occurs. In contrast, thermodynamics deals with state functions and describes the properties, behavior, and components of a system. It is not concerned with the path taken by the process and cannot address the rate at which a reaction occurs. Although it does provide information about what can happen during a reaction process, it does not describe the detailed steps of what appears on an atomic or a molecular level. On the other hand,...
10.9K
Imaging Studies for Cardiovascular System II:Types of Echocardiography01:20

Imaging Studies for Cardiovascular System II:Types of Echocardiography

Echocardiography plays a role in assessing cardiac health and detecting heart conditions, with various types providing critical insights for diagnosis and treatment.
Types of Echocardiography
Transthoracic Echocardiography (TTE)
TTE is the most common type of echocardiogram which involves placing a transducer on the patient's chest, emitting sound waves to create heart images. TTE is invaluable for evaluating the heart's size, structure, and motion, making it particularly useful for...
661
Heart Failure II: Pathophysiology01:29

Heart Failure II: Pathophysiology

Systolic Heart Failure and Compensatory MechanismsSystolic heart failure (also termed HFrEF, Heart Failure with Reduced Ejection Fraction) is the most prevalent type of heart filure. It results in a decreased volume of blood being pumped from the ventricle. The aortic arch and carotid sinuses have baroreceptors that detect reduced blood pressure, triggering the sympathetic nervous system (SNS) to release epinephrine and norepinephrine. Initially, this response aims to boost heart rate and...
975
Pathophysiology of Heart Failure01:17

Pathophysiology of Heart Failure

Heart failure (HF) is a progressive syndrome involving ventricles that leads to inadequate cardiac output. It can be classified based on location and output or ejection fraction. Ejection fraction (EF) is an essential measurement in the diagnosis and surveillance of HF. Reduced EF corresponds to systolic heart failure (HFrEF). However, HF with preserved ejection fraction (HFpEF) is becoming increasingly prevalent. Also known as diastolic HF, this form of HF is related to aging. The...
3.8K
Heart Failure I: Introduction01:27

Heart Failure I: Introduction

Heart failure refers to a clinical syndrome caused by structural or functional cardiac disorders that prevent the heart from pumping an adequate amount of blood to meet the body's metabolic needs. This condition often arises from myocardial infarction or ischemia, leading to decreased cardiac output, reduced tissue perfusion, impaired gas exchange, fluid volume imbalance, and decreased functional ability.Heart failure can result from disruptions in the mechanisms that regulate cardiac output...
924